Popular in Course
verified elite notetaker
Popular in Business
This 5 page Document was uploaded by an elite notetaker on Monday December 21, 2015. The Document belongs to a course at a university taught by a professor in Fall. Since its upload, it has received 26 views.
Reviews for Trends-in-Immunology-Market-Partnering-Terms-and-Agreements
Report this Material
What is Karma?
Karma is the currency of StudySoup.
You can buy or earn more Karma at anytime and redeem it for class notes, study guides, flashcards, and more!
Date Created: 12/21/15
IMMUNOLOGY P ARTNERING T ERMS AND AGREEMENTS Published: March 2014 No of Pages: 1159 Single User PDF: US$ 2995 Corporate User PDF: US$ 14995 ImmunologyPartnering Terms and Agreements The Immunology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the immunology partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter immunology partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors immunology technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not. Delivery of this report will take 1-3 days after purchase. Complete report available @ http://www.lifescienceindustryresearch.com/immunology-partnering-terms-and- agreements.html. ImmunologyPartnering Terms and Agreements This report contains over 1,000 links to online copies of actual immunology deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal. The initial chapters of this report provide an orientation of immunology dealmaking and business activities. Chapter 1 provides an introduction to the report. Chapter 2 provides an overview of the trends in immunology dealmaking since 2009 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development. Chapter 3 provides a review of the leading immunology deals since 2009. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract. Delivery of this report will take 1-3 days after purchase. Order a copy of this report at @ http://www.lifescienceindustryresearch.com/purchase?rname=3800. ImmunologyPartnering Terms and Agreements In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of immunology technologies and products. Benefits Immunology Partnering Terms and Agreements provides the reader with the following key benefits: In-depth understanding of immunology deal trends since 2009 Access immunology deal headline, upfront, milestone and royalty data Research hundreds of actual contracts between immunology partner companies Comprehensive access to over 1,000 links to actual immunology deals entered into by the world’s biopharma companies Indepth review of immunology deals entered into by the leading fifty bigpharma companies Benchmark the key deal terms companies have agreed in previous deals Identify key terms under which companies partner immunology opportunities Uncover companies actively partnering immunology opportunities Delivery of this report will take 1-3 days after purchase. Inquire Before Buying @ http://www.lifescienceindustryresearch.com/inquire-before- buying?rname=3800. A BOUT US LIFSCIENCE NDUSTRY RESEARCH BRINGS TO YOU TO THE LATEST REPORTS IN MARKET RESEARCH ON BIOTECHNOLOGY, IAGNOSTICS, HEALTHCAR, M EDICALDEVICES AND PHARMACEUTICALS SEGMENTS FROM LEADING RESEARCH PUBLISHERS ACROSS THE GLOBE. HESE REPORTS ALSO COVER DATA AND INFORMATION ON S-SEGMENTS AND SECTORS UNDER THESE LIFE SCIENCES CATEGO.IES CONTACT US SALES@ LIFESCIENCEINDUSTRYRESEAR.COM / + 1 888 391 5441) FOR ANY OF YOUR RESEARCH REQUIREMENTS OR TOPICS OF INTE. OUR SALES& RESEARCH ASSOCIATES WILL BE HAPPY TO HELP YOU FIND RELEVANT MARKET.DATA W EBSITE :WWW LIFESCIENCEINDUSTRYRESEARCH .COM Browse Latest Industry News, Updates, Trends, Opportunities, Scenario all over the world @
Are you sure you want to buy this material for
You're already Subscribed!
Looks like you've already subscribed to StudySoup, you won't need to purchase another subscription to get this material. To access this material simply click 'View Full Document'